Effects of Whole-Body Irradiation From External Radiation or Internal Absorption

Phase of Syndrome

Feature

Dose Range (Gy)*, †

1–2

2–6

6–8

8–30

> 30

Prodrome

Incidence of nausea and vomiting

5–50%

50–100%

75–100%

90–100%

100%

Time of onset of nausea and vomiting after exposure‡

2–6 hours

1–2 hours

10–60 minutes

< 10 minutes

Minutes

Duration of nausea and vomiting

< 24 hours

24–48 hours

< 48 hours

< 48 hours

N/A (patients die in < 48 hours)

Severity and incidence of diarrhea

None

None to mild (< 10%)

Moderate to Severe (> 10%)

Severe (> 95%)

Severe (100%)

Time of onset of diarrhea after exposure

3–8 hours

1–3 hours

< 1 hour

< 1 hour

Severity and incidence of headache

Slight

Mild to moderate (50%)

Moderate (80%)

Severe (80–90%)

Severe (100%)

Time of onset of headache after exposure

4–24 hours

3–4 hours

1–2 hours

< 1 hour

Severity of fever

Afebrile

Moderate increase

Moderate to severe

Severe

Severe

Incidence of fever

10–100%

100%

100%

100%

Time of onset of fever after exposure

1–3 hours

< 1 hour

< 1 hour

< 1 hour

Central nervous system function

No impairment

Cognitive impairment for 6–20 hours

Cognitive impairment for > 24 hours

At higher doses, rapid incapacitation

May have a lucid interval of several hours

Ataxia

Seizures

Tremor

Lethargy

Latent period

No symptoms

28–31 days

7–28 days

< 7 days

None

None

Overt illness

Clinical manifestations

Mild to moderate leukopenia

Fatigue

Weakness

Moderate to severe leukopenia

Purpura

Hemorrhage

Infections

Epilation after 3 Gy

Severe leukopenia

High fever

Diarrhea

Vomiting

Dizziness and disorientation

Hypotension

Electrolyte disturbance

Nausea

Vomiting

Severe diarrhea

High fever

Electrolyte disturbance

Shock

N/A (patients die in < 48 hours)

Dominant organ system syndrome

Hematopoietic

Hematopoietic

Gastrointestinal (mucosal cells)

Gastrointestinal (mucosal cells)

Central nervous system

Hospitalization

Outpatient observation

Recommended to necessary

Urgent

Palliative treatment (symptomatic only)

Palliative treatment (symptomatic only)

Acute mortality without medical care

0–5%

5–100%

95–100%

100%

100%

Acute mortality with medical care

0–5%

5–50%

50–100%

100%

100%

Death

6–8 weeks

4–6 weeks

2–4 weeks

2 days–2 weeks

1–2 days

* 1 rad = 1 cGy; 100 rad = 1 Gy.

† Whole-body irradiation of up to ~1 Gy is unlikely to cause any symptoms.

‡ Although time to emesis is a rapid and inexpensive method for estimating radiation dose, it should be used with caution because it is imprecise and has a high false-positive rate. Additional information, such as lymphocyte counts and details of the potential for exposure, improve accuracy.

Adapted from Military Medical Operations Armed Forces Radiobiology Research Institute: Medical Management of Radiological Casualties, edition 3. June 2010.